Alpha Tau Medical Ltd. (DRTSW)Jerusalem, Israel | NasdaqCM
2.68 USD
-0.31
(-10.368%) ⇩
(Oct. 16, 2026, 3:51 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 10:48 a.m. EDT
The immediate outlook is severely clouded by a relentless downward trend, with the stock testing critical support levels and sliding significantly in recent sessions. This weakness is compounded by a complete lack of price history, preventing any assessment of a recovery pattern or momentum shift. Fundamentally, the business is in distress, generating negative free cash flow and posting severe losses on both assets and equity, which suggests the core operations are failing to generate value. There is no dividend to provide income or a buffer against these operational headwinds. While the balance sheet shows low debt relative to equity, the inability to generate cash and the persistent price declines indicate a company struggling to survive rather than a speculative opportunity poised for a turnaround. |
| Attribute | Value |
|---|---|
| Debt to Equity Ratio | 34.393 |
| Beta | 1.22 |
| Website | https://www.alphatau.com |
| Attribute | Value |
|---|---|
| Address1 | Kiryat HaMada St. 5 |
| Ask | 0.0 |
| Ask Size | 0 |
| Beta | 1.224 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | 0.477 |
| City | Jerusalem |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Israel |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.68 |
| Current Ratio | 11.091 |
| Custom Price Alert Confidence | HIGH |
| Day High | 2.97 |
| Day Low | 2.355 |
| Debt To Equity | 34.393 |
| Ebitda | -48,760,000 |
| Ebitda Margins | 0.0 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 2.97 |
| Fifty Two Week High Change | -0.28999996 |
| Fifty Two Week High Change Percent | -0.097643085 |
| Fifty Two Week Low | 2.355 |
| Fifty Two Week Low Change | 0.32500005 |
| Fifty Two Week Low Change Percent | 0.13800426 |
| Fifty Two Week Range | 2.355 - 2.97 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,784,295,000,000 |
| Float Shares | 64,101,174 |
| Free Cashflow | -20,261,876 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 121 |
| Fullday Change | -0.31999993 |
| Fullday Change Percent | -10.66702 |
| Fullday Price | 2.68 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Ipo Expected Date | 2,022-03-08 |
| Language | en-US |
| Long Business Summary | Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel. |
| Long Name | Alpha Tau Medical Ltd. |
| Market | us_market |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_531816986 |
| Net Income To Common | -92,574,000 |
| Open | 0.3251 |
| Operating Cashflow | -12,814,000 |
| Operating Margins | 0.0 |
| Phone | 972 3 577 4115 |
| Previous Close | 2.99 |
| Price Hint | 4 |
| Price To Book | 5.6184487 |
| Profit Margins | 0.0 |
| Quick Ratio | 10.448 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.30999994 |
| Regular Market Change Percent | -10.367891 |
| Regular Market Day High | 2.97 |
| Regular Market Day Low | 2.355 |
| Regular Market Day Range | 2.355 - 2.97 |
| Regular Market Open | 0.3251 |
| Regular Market Previous Close | 2.99 |
| Regular Market Price | 2.68 |
| Regular Market Time | 1,792,180,297 |
| Regular Market Volume | 43,368 |
| Return On Assets | -0.25707 |
| Return On Equity | -1.41683 |
| Sand P52 Week Change | 0.16207206 |
| Sector | |
| Sector Key | |
| Short Name | Alpha Tau Medical Ltd. Warrant |
| Source Interval | 15 |
| Symbol | DRTSW |
| Total Cash | 100,639,000 |
| Total Cash Per Share | 1.09 |
| Total Debt | 15,152,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 43,368 |
| Website | https://www.alphatau.com |
| Zip | 9,777,605 |